{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:00:32Z","timestamp":1787238032641,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    This study aimed to explore if viable\n                    <jats:italic>C. burnetii<\/jats:italic>\n                    avirulent Nine Mile phase II (NMII) can elicit protective immunity against virulent NM phase I (NMI) infection. Interestingly, mice immunized with viable NMII elicited significant protection against NMI infection at different time points post-immunization. Viable NMII induced a dose-dependent NMI-specific IgG response in mice, but all doses of NMII-immunized mice conferred a similar level of protection. Comparing different routes of immunization indicated that intranasally immunized mice showed significantly higher levels of protection than other immunization routes. The observation that viable NMII induced a similar level of long-term protection against NMI challenge as the formalin-inactivated NMI vaccine (PIV) suggests that viable NMII bacteria can induce a similar level of long-term protection against virulent NMI challenge as the PIV. Viable NMII also induced significant protection against challenge with virulent Priscilla and Scurry strains, suggesting that viable NMII can elicit broad protection. Immune sera and splenocytes from viable NMII-immunized mice are protective against NMI infection, but immune serum-receiving mice did not control NMI replication. Additionally, viable NMII conferred a comparable level of protection in wild-type, CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell-deficient, and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell-deficient mice, and partial protection in B cell-deficient mice. However, NMII-immunized T cell-deficient mice were unable to prevent\n                    <jats:italic>C. burnetii<\/jats:italic>\n                    replication. Thus, both B cells and T cells are required for viable NMII-induced protective immunity but T cells may play a critical role. Collectively, this study demonstrates the feasibility of using avirulent NMII as a live attenuated vaccine against human Q fever.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.754690","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T02:46:52Z","timestamp":1634784412000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["The Feasibility of Using Coxiella burnetii Avirulent Nine Mile Phase II Viable Bacteria as a Live Attenuated Vaccine Against Q fever"],"prefix":"10.3389","volume":"12","author":[{"given":"Venkatesh","family":"Kumaresan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawkat","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"key":"B1","article-title":"Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review. Final Rule","volume":"77","year":"2012","journal-title":"Fed Regist"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.05.029","article-title":"Coxiella Burnetii-Positive PCR in Febrile Patients in Rural and Urban Africa","volume":"28","author":"Angelakis","year":"2014","journal-title":"Int J Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.14-0282","article-title":"Q Fever in French Guiana","volume":"91","author":"Eldin","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/S0950268811000136","article-title":"Low Seroprevalence of Q Fever in The Netherlands Prior to a Series of Large Outbreaks","volume":"140","author":"Schimmer","year":"2012","journal-title":"Epidemiol Infect"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0131777","DOI":"10.1371\/journal.pone.0131777","article-title":"Population Screening for Chronic Q-Fever Seven Years After a Major Outbreak","volume":"10","author":"Morroy","year":"2015","journal-title":"PloS One"},{"key":"B6","first-page":"1","article-title":"Diagnosis and Management of Q Fever\u2013United States, 2013: Recommendations From CDC and the Q Fever Working Group","volume":"62","author":"Anderson","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268803008343","article-title":"The Effect of C. Burnetii Infection on the Quality of Life of Patients Following an Outbreak of Q Fever","volume":"130","author":"Hatchette","year":"2003","journal-title":"Epidemiol Infect"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800059458","article-title":"Vaccine Prophylaxis of Abattoir-Associated Q Fever: Eight Years\u2019 Experience in Australian Abattoirs","volume":"104","author":"Marmion","year":"1990","journal-title":"Epidemiol Infect"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0205882","DOI":"10.1371\/journal.pone.0205882","article-title":"Standardized Guinea Pig Model for Q Fever Vaccine Reactogenicity","volume":"13","author":"Baeten","year":"2018","journal-title":"PloS One"},{"key":"B10","article-title":"Combined Vaccination of Live 1B Chlamydophila Abortus and Killed Phase I Coxiella Burnetii Vaccine Does Not Destroy Protection Against Chlamydiosis in a Mouse Model","volume":"68","author":"Rekiki","year":"2004","journal-title":"Can J Vet Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.04.010","article-title":"Effect of Vaccination With Phase I and Phase II Coxiella Burnetii Vaccines in Pregnant Goats","volume":"23","author":"Arricau-Bouvery","year":"2005","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201622","article-title":"Development of a Lipopolysaccharide-Targeted Peptide Mimic Vaccine Against Q Fever","volume":"189","author":"Peng","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1749-6632.1990.tb42203.x","article-title":"The Role of Lipopolysaccharides in the Virulence of Coxiella Burnetii","volume":"590","author":"Hackstadt","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.12.8372","article-title":"Mechanisms of Vaccine-Induced Protective Immunity Against Coxiella Burnetii Infection in BALB\/c Mice","volume":"179","author":"Zhang","year":"2007","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1006922","DOI":"10.1371\/journal.ppat.1006922","article-title":"Genetic Mechanisms of Coxiella Burnetii Lipopolysaccharide Phase Variation","volume":"14","author":"Beare","year":"2018","journal-title":"PloS Pathog"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/genomeA.00471-17","article-title":"Whole-Genome Sequence of Coxiella Burnetii Nine Mile RSA439 (Phase II, Clone 4), a Laboratory Workhorse Strain","volume":"5","author":"Millar","year":"2017","journal-title":"Genome Announc"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/JB.188.7.2309-2324.2006","article-title":"Genetic Diversity of the Q Fever Agent, Coxiella Burnetii, Assessed by Microarray-Based Whole-Genome Comparisons","volume":"188","author":"Beare","year":"2006","journal-title":"J Bacteriol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.12.6726-2733.2002","article-title":"Chromosomal DNA Deletions Explain Phenotypic Characteristics of Two Antigenic Variants, Phase II and RSA 514 (Crazy), of the Coxiella Burnetii Nine Mile Strain","volume":"70","author":"Hoover","year":"2002","journal-title":"Infect Immun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-132-9-2587","article-title":"Overlapping Deletion in Two Spontaneous Phase Variants of Coxiella Burnetii","volume":"132","author":"Vodkin","year":"1986","journal-title":"J Gen Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/iai.48.2.359-365.1985","article-title":"Lipopolysaccharide Variation in Coxiella Burnetti: Intrastrain Heterogeneity in Structure and Antigenicity","volume":"48","author":"Hackstadt","year":"1985","journal-title":"Infect Immun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"Unit 6C.1","DOI":"10.1002\/9780471729259.mc06c01s15","article-title":"Laboratory Maintenance of Coxiella Burnetii","author":"Samuel","year":"2009","journal-title":"Curr Protoc Microbiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.1.40-44.1988","article-title":"Lipopolysaccharide Phase Variation Determines the Complement-Mediated Serum Susceptibility of Coxiella Burnetii","volume":"56","author":"Vishwanath","year":"1988","journal-title":"Infect Immun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00504-17","article-title":"Coxiella Burnetii Inhibits Neutrophil Apoptosis by Exploiting Survival Pathways and Antiapoptotic Protein Mcl-1","volume":"86","author":"Cherla","year":"2018","journal-title":"Infect Immun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00694-16","article-title":"Coxiella Burnetii Avirulent Nine Mile Phase II Induces Caspase-1-Dependent Pyroptosis in Murine Peritoneal B1a B Cells","volume":"84","author":"Schoenlaub","year":"2016","journal-title":"Infect Immun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2019.1575715","article-title":"Comparative Virulence of Diverse Coxiella Burnetii Strains","volume":"10","author":"Long","year":"2019","journal-title":"Virulence"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/iai.55.5.1144-1150.1987","article-title":"Comparative Virulence of Intra- and Interstrain Lipopolysaccharide Variants of Coxiella Burnetii in the Guinea Pig Model","volume":"55","author":"Moos","year":"1987","journal-title":"Infect Immun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01767-06","article-title":"T Cells Are Essential for Bacterial Clearance, and Gamma Interferon, Tumor Necrosis Factor Alpha, and B Cells are Crucial for Disease Development in Coxiella Burnetii Infection in Mice","volume":"75","author":"Andoh","year":"2007","journal-title":"Infect Immun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00025","article-title":"The SCID Mouse Model for Identifying Virulence Determinants in Coxiella Burnetii","volume":"7","author":"van Schaik","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"8722","DOI":"10.1073\/pnas.0501863102","article-title":"Virulent Coxiella Burnetii Does Not Activate Human Dendritic Cells: Role of Lipopolysaccharide as a Shielding Molecule","volume":"102","author":"Shannon","year":"2005","journal-title":"PNAS"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2017.1407035","article-title":"Understanding Modern-Day Vaccines: What You Need to Know","volume":"50","author":"Vetter","year":"2018","journal-title":"Ann Med"},{"key":"B31","article-title":"Chapter 21 - Vaccines","volume-title":"Pharmaceutical Medicine and Translational Clinical Research","author":"Bhardwaj","year":"2018"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00261-16","article-title":"Complementation of Arginine Auxotrophy for Genetic Transformation of Coxiella Burnetii by Use of a Defined Axenic Medium","volume":"82","author":"Sandoz","year":"2016","journal-title":"Appl Environ Microbiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00824-19","article-title":"Major Histocompatibility Complex Class II-Restricted, CD4(+) T Cell-Dependent and -Independent Mechanisms Are Required for Vaccine-Induced Protective Immunity Against Coxiella Burnetii","volume":"88","author":"Ledbetter","year":"2020","journal-title":"Infect Immun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00207","article-title":"Promiscuous Coxiella Burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine","volume":"10","author":"Scholzen","year":"2019","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw470","article-title":"Identification of Coxiella Burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria Monocytogenes as a Vaccine Vector in a C57BL\/6 Mouse Model","volume":"215","author":"Xiong","year":"2016","journal-title":"J Infect Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4049\/jimmunol.1900991","article-title":"Tuning Subunit Vaccines With Novel TLR Triagonist Adjuvants to Generate Protective Immune Responses Against Coxiella Burnetii","volume":"204","author":"Gilkes","year":"2020","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00973-13","article-title":"Coxiella Burnetii Interaction With Neutrophils and Macrophages In Vitro and in SCID Mice Following Aerosol Infection","volume":"81","author":"Elliott","year":"2013","journal-title":"Infect Immun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02022","article-title":"Quantitative Proteome Profiling of Coxiella Burnetii Reveals Major Metabolic and Stress Differences Under Axenic and Cell Culture Cultivation","volume":"10","author":"Dresler","year":"2019","journal-title":"Front Microbiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2007.00901.x","article-title":"Lounging in a Lysosome: The Intracellular Lifestyle of Coxiella Burnetii","volume":"9","author":"Voth","year":"2007","journal-title":"Cell Microbiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1128\/IAI.00406-10","article-title":"Coxiella Burnetii Phase I and II Variants Replicate With Similar Kinetics in Degradative Phagolysosome-Like Compartments of Human Macrophages","volume":"78","author":"Howe","year":"2010","journal-title":"Infect Immun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/vaccines6040083","article-title":"Frequency of Adverse Events Following Q Fever Immunisation in Young Adults","volume":"6","author":"Sellens","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2014.01.006","article-title":"New Advances in Mucosal Vaccination","volume":"161","author":"Ranasinghe","year":"2014","journal-title":"Immunol Lett"},{"key":"B43","volume-title":"Epidemiology and Prevention of Vaccine-Preventable Diseases","author":"Atkinson","year":"2011"},{"key":"B44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2567.2011.03517.x","article-title":"T-Cell-Inducing Vaccines - What\u2019s the Future","volume":"135","author":"Gilbert","year":"2012","journal-title":"Immunology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.4.781","article-title":"Markers of Cell-Mediated Immunity After Vaccination With an Inactivated, Whole-Cell Q Fever Vaccine","volume":"157","author":"Izzo","year":"1988","journal-title":"J Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.754690\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T13:22:48Z","timestamp":1635859368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.754690\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2021.754690"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.754690","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"article-number":"754690"}}